Leukine (sargramostim)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Leukine (sargramostim), covering 2015-03-25 to 2025-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer [Phase 1]